PROK logo

PROKProKidney Corp

$1.67
$0.00
(0.00%)
Today
Closed $1.67
$0.01
(0.60%)
After Hours
Updated: 07:05 PM EDT
Reported EarningsMay 15
Mkt Cap$504.44M
Vol671,527.00
News
all
press releases
ProKidney Corp. (PROK) Reports Q1 Loss, Tops Revenue Estimates
PROKIDNEY CP (PROK) delivered earnings and revenue surprises of -7.69% and +222.86%, respectively, for the quarter ended March 2026. Do the numbers hold clues to what lies ahead for the stock?
Zacks
News Placeholder
More News
News Placeholder
ARS Pharmaceuticals, Inc. (SPRY) Reports Q1 Loss, Beats Revenue Estimates
ARS Pharmaceuticals, Inc. (SPRY) delivered earnings and revenue surprises of -15.09% and +2.01%, respectively, for the quarter ended March 2026. Do the numbers hold clues to what lies ahead for the stock?
Zacks
News Placeholder
Karyopharm Therapeutics (KPTI) Reports Q1 Loss, Beats Revenue Estimates
Karyopharm Therapeutics (KPTI) delivered earnings and revenue surprises of +14.48% and +3.34%, respectively, for the quarter ended March 2026. Do the numbers hold clues to what lies ahead for the stock?
Zacks
News Placeholder
ProKidney (PROK) to Release Quarterly Earnings on Monday
ProKidney (NASDAQ:PROK) will be releasing its Q1 2026 earnings before the market opens on Monday, May 11. (View Earnings Report at https://www.marketbeat.com/earnings/reports/2026-5-11-prokidney-corp-stock...
MarketBeat
News Placeholder
ProKidney (NASDAQ:PROK) Upgraded to Sell at Wall Street Zen
Wall Street Zen upgraded ProKidney from a "strong sell" rating to a "sell" rating in a research report on Saturday...
MarketBeat
News Placeholder
ProKidney (NASDAQ:PROK) Stock Price Up 9% - Should You Buy?
ProKidney (NASDAQ:PROK) Trading 9% Higher - Here's What Happened...
MarketBeat
News Placeholder
ProKidney Corp. (NASDAQ:PROK) Receives Consensus Recommendation of "Moderate Buy" from Brokerages
Shares of ProKidney Corp. (NASDAQ:PROK - Get Free Report) have been assigned a consensus recommendation of "Moderate Buy" from the eight research firms that are presently covering the firm, Marketbeat Ratings reports. Two analysts have rated the stock with a sell recommendation, one has issued a...
MarketBeat
News Placeholder
ProKidney (NASDAQ:PROK) Sees Strong Trading Volume - Time to Buy?
ProKidney (NASDAQ:PROK) Sees Strong Trading Volume - What's Next...
MarketBeat
News Placeholder
Hennion & Walsh Asset Management Inc. Has $3.37 Million Holdings in ProKidney Corp. $PROK
Hennion & Walsh Asset Management Inc. lifted its stake in shares of ProKidney Corp. (NASDAQ:PROK - Free Report) by 63.5% in the 4th quarter, according to its most recent Form 13F filing with the...
MarketBeat
News Placeholder
ProKidney (NASDAQ:PROK) Shares Up 5.9% - Here's Why
ProKidney (NASDAQ:PROK) Trading 5.9% Higher - What's Next...
MarketBeat
<
1
2
...
>

Advertisement|Remove ads.